Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 2Breast Neoplasms 2Smoking 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Peripheral Nervous System Diseases 1Overweight 1Obesity 1Motor Activity 1Meningioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Lymphoma 1Localized Prostate Cancer 1Leukemia, Myeloid, Acute 1Leukemia 1Infertility 1HER2 IHC3+ Advanced Colorectal Cancer 1Genetic Diseases, Inborn 1Cognitive Dysfunction 1

Interventions

pembrolizumab 2enfortumab vedotin 2Acupuncture Therapy 2Thioctic Acid 1Tablets 1Single Person 1Rosuvastatin Calcium 1Memantine 1Fish Oils 1Exercise 1Corn Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Tablets × 90 days × Clear all
NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Tanta University

Phase 2/3 Not yet recruiting
46 enrolled

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡